CVS Health Corp

CVS Health Corp’s stock price has fluctuated following its recent earnings report, but analysts at Mizuho are optimistic about the company’s potential for growth, increasing their price target to $70.

CVS Health is facing intense scrutiny as it prepares to unveil its fourth-quarter results, with analysts expecting a decline in earnings per share and the company’s turnaround efforts under close watch.